Augusto Villanueva

Augusto Villanueva

Icahn School of Medicine at Mount Sinai

H-index: 79

North America-United States

About Augusto Villanueva

Augusto Villanueva, With an exceptional h-index of 79 and a recent h-index of 64 (since 2020), a distinguished researcher at Icahn School of Medicine at Mount Sinai, specializes in the field of Cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Bispectral index monitoring for sedation in scheduled adult colonoscopy: A randomized controlled trial

Author Correction: Hepatocellular carcinoma

PREDICTING RESPONSE TO ATEZOLIZUMAB PLUS BEVACIZUMAB IN ADVANCED HEPATOCELLULAR CARCINOMA

Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification

Pediatric Patient-Derived-Xenograft development in MAPPYACTS–international pediatric cancer precision medicine trial in relapsed and refractory tumors

Orthotopic xenografts models in relapse/refractory lymphomas: a preclinical model for therapeutic, mechanistic and functional studies

Metabolomic liquid biopsy dynamics predict early onset of human hepatocarcinogenesis

Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma

Augusto Villanueva Information

University

Position

___

Citations(all)

35831

Citations(since 2020)

19587

Cited By

25886

hIndex(all)

79

hIndex(since 2020)

64

i10Index(all)

162

i10Index(since 2020)

128

Email

University Profile Page

Icahn School of Medicine at Mount Sinai

Google Scholar

View Google Scholar Profile

Augusto Villanueva Skills & Research Interests

Cancer

Top articles of Augusto Villanueva

Title

Journal

Author(s)

Publication Date

Bispectral index monitoring for sedation in scheduled adult colonoscopy: A randomized controlled trial

Revista Española de Anestesiología y Reanimación (English Edition)

I González Mendibil

E García Pascual

A Villanueva

S García Gutiérrez

2024/4/23

Author Correction: Hepatocellular carcinoma

Josep M Llovet

Robin Kate Kelley

Augusto Villanueva

Amit G Singal

Eli Pikarsky

...

2024/2/12

PREDICTING RESPONSE TO ATEZOLIZUMAB PLUS BEVACIZUMAB IN ADVANCED HEPATOCELLULAR CARCINOMA

HEPATOLOGY

Sarah Cappuyns

Marta Pique-Gili

Roger Esteban-Fabro

Gino Philips

Roser Pinyol

...

2023/10/1

Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification

Gut

Carla Montironi

Florian Castet

Philipp K Haber

Roser Pinyol

Miguel Torres-Martin

...

2023/1/1

Pediatric Patient-Derived-Xenograft development in MAPPYACTS–international pediatric cancer precision medicine trial in relapsed and refractory tumors

Costa MEMd

S Zaidi

J Scoazec

R Droit

WC Lim

...

2023/2/22

Orthotopic xenografts models in relapse/refractory lymphomas: a preclinical model for therapeutic, mechanistic and functional studies

Hematological Oncology

E Domingo Domenech

F Climent

E Gonzalez Barca

E de Lama

P Lopez‐Pereira

...

2023/6

Metabolomic liquid biopsy dynamics predict early onset of human hepatocarcinogenesis

Zeitschrift für Gastroenterologie

Kornelius Schulze

Tim Daniel Rose

Lorenz Adlung

Manuela Peschka

Thorben W Fründt

...

2023/8

Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma

Gastroenterology

Philipp K Haber

Florian Castet

Miguel Torres-Martin

Carmen Andreu-Oller

Marc Puigvehí

...

2023/1/1

Discriminatory changes in circulating metabolites as a predictor of hepatocellular cancer in patients with metabolic (Dysfunction) associated fatty liver disease

Liver Cancer

Haonan Lu

Jacob George

Mohammed Eslam

Augusto Villanueva

Luigi Bolondi

...

2023/2/22

IKKα kinase coordinates BRD4 and STAT3 signaling to subvert DNA damage-based anticancer therapy

Irene Pecharroman

Laura Sole

Daniel Alvarez Villanueva

Joan Bertran

Yolanda Guillén

...

2023/5/8

WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinoma

Nature Cancer

Alex Rialdi

Mary Duffy

Alex P Scopton

Frank Fonseca

Julia Nanyi Zhao

...

2023/8

Small unannotated, non-coding rnas for the detection of liver cancer

2023/1/26

Clinical prediction rules for adverse evolution in patients with COVID-19 by the Omicron variant

International Journal of Medical Informatics

Janire Portuondo-Jiménez

Irantzu Barrio

Pedro P España

Julia García

Ane Villanueva

...

2023/5/1

Impact of prior SARS-COV-2 infection and vaccination on COVID-19 hospital admission and mortality amongst nursing home residents

Aging Clinical and Experimental Research

Pedro P España

Amaia Bilbao-González

Nere Larrea

Idoia Castillo-Sintes

Susana García-Gutiérrez

...

2023/8

Factors related to early readmissions after acute heart failure: a nested case–control study

BMC cardiovascular disorders

Susana Garcia-Gutierrez

Ane Villanueva

Iratxe Lafuente

Ibon Rodriguez

Ainara Lozano-Bahamonde

...

2023/1/12

Sublethal necroptosis signaling promotes inflammation and liver cancer

Immunity

Mihael Vucur

Ahmed Ghallab

Anne T Schneider

Arlind Adili

Mingbo Cheng

...

2023/7/11

Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications

Gut

Miguel A Martin-Serrano

Benjamin Kepecs

Miguel Torres-Martin

Emily R Bramel

Philipp K Haber

...

2023/4/1

Biomarkers for immunotherapy of hepatocellular carcinoma

Tim F Greten

Augusto Villanueva

Firouzeh Korangy

Benjamin Ruf

Mark Yarchoan

...

2023/11

Influencia del índice de privación social en resultados durante la pandemia de COVID-19

Gaceta Sanitaria

Janire Portuondo-Jiménez

María Gascón

Julia García

María-José Legarreta

Ane Villanueva

...

2023/1/1

MmCMS: mouse models’ consensus molecular subtypes of colorectal cancer

British Journal of Cancer

Raheleh Amirkhah

Kathryn Gilroy

Sudhir B Malla

Tamsin RM Lannagan

Ryan M Byrne

...

2023/3/30

See List of Professors in Augusto Villanueva University(Icahn School of Medicine at Mount Sinai)